Almac and TTP Labtech form alliance in fluorescence lifetime technology
Almac and TTP Labtech announced the formation of an alliance in the field of fluorescence lifetime (FLT) technology to provide screening performance.
FLT as a reading modality offers a robust, antibody-free, homogeneous assay platform which enables the user to avoid interference from fluorescent compounds within a screening library. Developed utilising experience in peptide engineering and chemical synthesis and design, Almac’s FLEXYTE™ assays harness potential of FLT to provide an efficient and economical platform for screening and profiling. The evolving assay platform offers solutions for many major therapeutic target classes including kinases, proteases, phosphatases, DUB and an increasing number of epigenetic targets.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Threading the Molecular Needle: ASU Biodesign Researcher to Explore Revolutionary Gene Sequencing - National Institutes of Health awarded a $550,000 three-year grant
Link Technologies Awarded ISO Quality Certification and Opens New Kilo Labs

A new method for atomic-resolution electron microscopes - Electron lens formed by light
VTT has developed a rapid image analysis method to help diagnose Alzheimer's disease
New Study Unveils Structure of Key Component of Antibiotic Resistant Bacteria - Findings Could Offer Help in Fighting Resistant Strains of Gonorrhea

Scars: gone with the foam - Prevent excessive scarring
Fluidigm Opens Singapore's First Biochip Fab - Breakthrough technology to be introduced at company's first offshore R&D and Manufactured facility
